TC-D101
/ TCRCure
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 25, 2025
TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: TCRCure Biopharma Ltd.
New P1 trial • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1